[Aspirin for secondary prevention of venous thromboembolism. WARFASA: Far from being conclusive.]

Aurélien Delluc; Karine Lacut; Dominique Mottier

doi:10.1016/j.revmed.2012.10.363

Journal articles

[Aspirin for secondary prevention of venous thromboembolism. WARFASA: Far from being conclusive.]

Aurélien Delluc ^{1, 2, *} Karine Lacut ^{2, 3} Dominique Mottier ^{2, 3}

* Corresponding author

1 DMIP - Brest - Département de Médecine Interne et Pneumologie [Brest]

2 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale

3 CIC - Brest - Centre d'Investigation Clinique

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology

Complete list of metadata

https://hal.univ-brest.fr/hal-00758188
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Wednesday, November 28, 2012 - 11:52:57 AM
Last modification on : Thursday, March 31, 2022 - 11:00:02 AM

[Aspirin for secondary prevention of venous thromboembolism. WARFASA: Far from being conclusive.]

Identifiers

Collections

Citation

Export

Metrics

14

[Aspirin for secondary prevention of venous thromboembolism. WARFASA: Far from being conclusive.]

Identifiers

Collections

Citation

Export

Share

Metrics

14